Literature DB >> 4919024

Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trial.

N Oker-Blom, T Hovi, P Leinikki, T Palosuo, R Pettersson, J Suni.   

Abstract

Prophylactic administration of amantadine in doses of 100 mg. twice a day offered statistically significant protection against influenza A2 infection in a double-blind field trial involving 391 medical student volunteers during the influenza A2 Hong Kong epidemic in Helsinki in the winter of 1969. Serologically verified influenza, as measured by complement fixation and/or haemagglutination inhibition, occurred in 27 out of 192 students in the amantadine group against 57 out of 199 in the placebo group, giving a protection rate of 52%.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4919024      PMCID: PMC1701794          DOI: 10.1136/bmj.3.5724.676

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  17 in total

1.  Antiviral substances: 6-aminonicotinamide and 1-adamantanamine hydrochloride.

Authors:  S H Lee; P R Dobson; C E van Rooyen
Journal:  Chemotherapy       Date:  1966       Impact factor: 2.544

2.  Studies on the antiviral activity of amantadine hydrochloride.

Authors:  K W Cochran; H F Maassab; A Tsunoda; B S Berlin
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

3.  Effect of 1-adamantanamine hydrochloride on Rous sarcoma virus in vitro and in vivo.

Authors:  N Oker-Blom; L Andersen
Journal:  Eur J Cancer       Date:  1966-02       Impact factor: 9.162

4.  [On the preventive effect of amantadine hydrochloride in influenza and other respiratory viral infections].

Authors:  P Halonen; R Mujunen; R Mäntyjärvi
Journal:  Sotilaslaak Aikak       Date:  1965

5.  Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study.

Authors:  A W Galbraith; J S Oxford; G C Schild; G I Watson
Journal:  Lancet       Date:  1969-11-15       Impact factor: 79.321

6.  [The prevention of A2-influenza in children by chemoprophylaxis with amantadine hydrochloride].

Authors:  J J Quilligan; M Hirayama; H D Baernstein
Journal:  Schweiz Med Wochenschr       Date:  1966-12-17

7.  A field trial of amantadine prophylaxis in naturally-occurring acute respiratory illness.

Authors:  J F Finklea; A V Hennessy; F M Davenport
Journal:  Am J Epidemiol       Date:  1967-05       Impact factor: 4.897

8.  THE IN VIVO ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). I. PROPHYLACTIC AND THERAPEUTIC ACTIVITY AGAINST INFLUENZA VIRUSES.

Authors:  R R GRUNERT; J W MCGAHEN; W L DAVIES
Journal:  Virology       Date:  1965-06       Impact factor: 3.616

9.  ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

Authors:  W L DAVIES; R R GRUNERT; R F HAFF; J W MCGAHEN; E M NEUMAYER; M PAULSHOCK; J C WATTS; T R WOOD; E C HERMANN; C E HOFFMANN
Journal:  Science       Date:  1964-05-15       Impact factor: 47.728

10.  1-Adamantanamine hydrochloride: inhibition of Rous and Esh Sarcoma viruses in cell culture.

Authors:  A M Wallbank; R E Matter; N G Klinikowski
Journal:  Science       Date:  1966-06-24       Impact factor: 47.728

View more
  14 in total

Review 1.  The contribution of virology to contemporary medicine.

Authors:  C Stuart-Harris
Journal:  Br J Prev Soc Med       Date:  1975-03

Review 2.  Perspectives on antiviral use during pandemic influenza.

Authors:  F G Hayden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

Review 3.  Amantadine and rimantadine for influenza A in adults.

Authors:  T Jefferson; V Demicheli; C Di Pietrantonj; D Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 4.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

5.  The use of antiviral drugs for influenza: recommended guidelines for practitioners.

Authors:  Upton D Allen; Fred Y Aoki; H Grant Stiver
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

6.  Chemoprophylaxis of respiratory infections.

Authors:  J Batten
Journal:  Postgrad Med J       Date:  1976-09       Impact factor: 2.401

Review 7.  Antiviral agents: an update--Part I.

Authors:  S Bogger-Goren; P L Ogra
Journal:  Indian J Pediatr       Date:  1980 Sep-Oct       Impact factor: 1.967

8.  The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutant.

Authors:  Philippe Simon; Benjamin P Holder; Xavier Bouhy; Yacine Abed; Catherine A A Beauchemin; Guy Boivin
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

Review 9.  Amantadine and rimantadine for influenza A in children and the elderly.

Authors:  Márcia G Alves Galvão; Marilene Augusta Rocha Crispino Santos; Antonio J L Alves da Cunha
Journal:  Cochrane Database Syst Rev       Date:  2014-11-21

10.  Anti-influenza A virus activity of amantadine hydrochloride and rimantadine hydrochloride in ferret tracheal ciliated epithelium.

Authors:  D B Burlington; G Meiklejohn; S R Mostow
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.